RecruitingNCT07151339

Pilot Project Renal and Cardiovascular Tertiary Prevention in Preeclampsia

Pilotprojekt Renale Und kardiovaskuläre Tertiärprävention Nach Präeklampsie


Sponsor

University Hospital Schleswig-Holstein

Enrollment

100 participants

Start Date

Nov 1, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

Tertiary prevention program for women with preeclampsia, HELLP syndrome, kidney disease and pregnancy or associated conditions, including founding of a biobank. (Observational study since no interference with regular path of treatment suggested in national and international guidelines)


Eligibility

Sex: FEMALEMin Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This pilot study is following women who developed high blood pressure during pregnancy (preeclampsia), HELLP syndrome, or kidney problems during pregnancy, to track their long-term kidney and heart health. The goal is to help prevent future complications through early monitoring. **You may be eligible if...** - You are over 18 years old - You were diagnosed with preeclampsia, HELLP syndrome, or kidney disease during a pregnancy **You may NOT be eligible if...** - You are unable to give informed consent Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

University Hospital Schleswig- Holstein

Kiel, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07151339


Related Trials